Novel therapies for alopecia areata: The era of rational drug development.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29155099.
- Also identified by DOI 10.1016/j.jaci.2017.10.028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Treatments for alopecia areata (AA) have evolved over the decades from broad and nonspecific therapies to those that are now more targeted and rationally selected. This was achieved by means of close cooperation and communication between clinicians and basic scientists, which resulted in the elucidation and understanding of the unique pathophysiology of AA. In this review we discuss this evolution and how novel therapies for AA have changed over the decades, what we have in our current arsenal of drugs for this potentially devastating disease, and what the future holds.
Medical subject headings
- Alopecia Areata
- Drug Development